Back to search
FDAFDA · Food and drugs·Recall number D-0584-2026

Niacin Extended-release Tablets, USP, 1,000 mg, 90-count bottles, Rx Only, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136, NDC 62175-322-46.

Published June 10, 2026 · Recall initiated: May 27, 2026

Summary

FDA records drug Class II recall D-0584-2026, published June 10, 2026 and initiated May 27, 2026. Recalling firm: Lannett Company Inc.; Status: Ongoing; Reported quantity: 3984 bottles; Lot: Lot #: 25282724A, Exp. Date 2027/01. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Dissolution Specifications: during 12M LT stability testing OOS low for Stage 3 dissolution at the 24-hour timepoint.

What to do

Voluntary: Firm initiated · Letter

Get an email if NIACIN has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
NIACIN
Manufacturer
Lannett Company Inc.
Distributor
Nationwide within the United States
UPC
0362175320469
Lot
Lot #: 25282724A, Exp. Date 2027/01
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Niacin Extended-release Tablets, USP, 1,000 mg, 90-count bottles, Rx Only, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136, NDC 62175-322-46. recalled?

Yes. FDA published recall D-0584-2026 on June 10, 2026. Reported hazard: Failed Dissolution Specifications: during 12M LT stability testing OOS low for Stage 3 dissolution at the 24-hour timepoint.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: NIACIN. UPC: 0362175320469.